Clin2
NCT07719127Likely a fitNot yet recruiting

Disulfiram before brain tumor surgery to reduce need for steroids

Brain (Nervous System) Cancers

Treatments studied

Part of Brain & nervous system, Cancer clinical trials.

This study tests whether a drug called disulfiram (commonly used for alcohol aversion) can help reduce immune suppression in the body and decrease the need for steroids in people with a high-grade brain tumor who are scheduled for surgery. Taking disulfiram before surgery may help the immune system fight the tumor better.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
20 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You must be 18 years or older.
  • You must have a high-grade glioma (a type of brain tumor) and be scheduled for surgery to remove it as part of your standard care.
  • You need to be able to start taking the study drug at least 3 days before your planned surgery, and you'll need to stay in the hospital for the study.
  • You must be generally healthy enough to carry out daily activities (Karnofsky score of 70% or higher).
  • You must not have used steroids (like dexamethasone) to treat brain swelling before starting this trial.
  • You must agree to avoid all alcohol and products containing alcohol during treatment and for 14 days after your last dose.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07003542Recruiting· Phase 2
Sitagliptin for people with high-grade brain tumors

This trial tests whether sitagliptin, a medicine usually used for diabetes, can help people with a fast-growing type of brain tumor (grade 4 glioma). You will take sitagliptin before your planned surgery, and researchers will study how it affects your tumor.

Cleveland, Ohio
NCT07438860Not yet recruiting· Phase 1
Safety study of a glowing dye for brain tumor surgery

This trial tests a dye (SBK2-ICG) that makes brain tumors glow during surgery. It's a safety study to see if the dye is safe and works well, which might help surgeons remove brain tumors more completely.

Cleveland, Ohio
NCT01777919Not yet recruiting· Phase 2
Disulfiram and copper for newly diagnosed brain cancer

This study tests a drug called disulfiram (usually used for alcohol addiction) combined with copper, given after surgery for newly diagnosed glioblastoma. The goal is to see if this combination can help stop the cancer from growing.

Pátrai
NCT07694089Not yet recruiting· Phase 2
Steroid-free approach with study drug for brain tumor surgery recovery

This trial tests whether avoiding steroids and using a study drug called azeliragon can help reduce brain swelling after surgery for a type of brain tumor called high-grade glioma. The goal is to improve recovery and reduce the need for steroids, which can have side effects.

Louisville, Kentucky
NCT04266977Recruiting
Low-dose steroid timing for newly diagnosed brain tumor surgery

This trial looks at using dexamethasone (a steroid medicine) in a more restricted way for people newly diagnosed with likely glioblastoma who are planned for brain surgery. The goal is to see whether limiting steroid use can still control symptoms while reducing steroid exposure.

Sankt Gallen, St.Gallen
NCT06132685Recruiting· Phase 2
Dexamethasone dosing after brain tumor surgery

This trial tests how to best use dexamethasone (a steroid) after brain tumor surgery to help recovery and reduce swelling. It looks at different dosing schedules for patients with common brain tumors.

Atlanta, Georgia

Hear when a new Brain (Nervous System) Cancers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.